Name | 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-1,3-dimethylpurine-2,6-dione |
---|---|
Synonyms |
Reproterol [INN:BAN]
EINECS 258-956-1 7-{3-[2-(3,5-dihydroxy-phenyl)-2-hydroxy-ethylamino]-propyl}-1,3-dimethyl-3,7-dihydro-purine-2,6-dione 7-{3-[2-(3,5-dihydroxyphenyl)-2-hydroxyethylamino]-propyl}-theophylline Theophylline,7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl) Reproterolum [INN-Latin] 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione 7-<3-<2-(3,5-dihydroxyphenyl)-2-hydroxyethylamino>propyl>-theophyllin D 1959 Reproterol |
Description | Reproterol is a dual acting β2-adrenoceptor agonist and PDE inhibitor. The theophylline constituent of Reproterol inhibits phosphodiesterase activity induced by adenylyl cyclase. Reproterol has the potential for asthma research[1][2]. |
---|---|
Related Catalog | |
Target |
β2 adrenoceptor |
References |
Density | 1.47g/cm3 |
---|---|
Boiling Point | 723.4ºC at 760mmHg |
Molecular Formula | C18H23N5O5 |
Molecular Weight | 389.41 |
Flash Point | 391.3ºC |
Exact Mass | 389.17000 |
PSA | 134.54000 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|